Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2017

Open Access 01-12-2017 | Study protocol

Transdiagnostic group CBT vs. standard group CBT for depression, social anxiety disorder and agoraphobia/panic disorder: Study protocol for a pragmatic, multicenter non-inferiority randomized controlled trial

Authors: Sidse M. Arnfred, Ruth Aharoni, Morten Hvenegaard, Stig Poulsen, Bo Bach, Mikkel Arendt, Nicole K. Rosenberg, Nina Reinholt

Published in: BMC Psychiatry | Issue 1/2017

Login to get access

Abstract

Background

Transdiagnostic Cognitive Behavior Therapy (TCBT) manuals delivered in individual format have been reported to be just as effective as traditional diagnosis specific CBT manuals. We have translated and modified the “The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders” (UP-CBT) for group delivery in Mental Health Service (MHS), and shown effects comparable to traditional CBT in a naturalistic study. As the use of one manual instead of several diagnosis-specific manuals could simplify logistics, reduce waiting time, and increase therapist expertise compared to diagnosis specific CBT, we aim to test the relative efficacy of group UP-CBT and diagnosis specific group CBT.

Methods/design

The study is a partially blinded, pragmatic, non-inferiority, parallel, multi-center randomized controlled trial (RCT) of UP-CBT vs diagnosis specific CBT for Unipolar Depression, Social Anxiety Disorder and Agoraphobia/Panic Disorder. In total, 248 patients are recruited from three regional MHS centers across Denmark and included in two intervention arms.
The primary outcome is patient-ratings of well-being (WHO Well-being Index, WHO-5), secondary outcomes include level of depressive and anxious symptoms, personality variables, emotion regulation, reflective functioning, and social adjustment. Assessments are conducted before and after therapy and at 6 months follow-up. Weekly patient-rated outcomes and group evaluations are collected for every session. Outcome assessors, blind to treatment allocation, will perform the observer-based symptom ratings, and fidelity assessors will monitor manual adherence.

Discussion

The current study will be the first RCT investigating the dissemination of the UP in a MHS setting, the UP delivered in groups, and with depressive patients included. Hence the results are expected to add substantially to the evidence base for rational group psychotherapy in MHS. The planned moderator and mediator analyses could spur new hypotheses about mechanisms of change in psychotherapy and the association between patient characteristics and treatment effect.

Trial registration

Clinicaltrials.gov NCT02954731. Registered 25 October 2016
Appendix
Available only for authorised users
Literature
1.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.CrossRefPubMed
2.
Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001;110(4):585–99.CrossRefPubMed
3.
Goldberg DP, Krueger RF, Andrews G, Hobbs MJ. Emotional disorders: cluster 4 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med. 2009;39(12):2043–59.CrossRefPubMed
4.
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.CrossRefPubMedPubMedCentral
5.
Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, Ehrenreich-May JT. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Therapist Guide. New York: Oxford University Press; 2011.
6.
Norton PJ. A randomized clinical trial of transdiagnostic cognitve-behavioral treatments for anxiety disorder by comparison to relaxation training. Behav Ther. 2012;43(3):506–17.CrossRefPubMed
7.
Barlow DH. Toward a Unified Treatment for Emotional Disorders. Behav Ther. 2004;35:2005–230.CrossRef
8.
McEvoy P, Nathan P, Norton P. Efficay of transdiagnostic treatments: A reveiw of published outcome studes and future research directions. J Cogn Psychother. 2009;23(1):20–33.CrossRef
9.
Norton PJ. An open trial of a transdiagnostic cognitive-behavioral group therapy for anxiety disorder. Behav Ther. 2008;39(3):242–50.CrossRefPubMed
10.
McManus F, Shafran R, Cooper Z. What does a transdiagnostic approach have to offer the treatment of anxiety disorders? Br J Clin Psychol. 2010;49(Pt 4):491–505.CrossRefPubMed
11.
Wilamowska ZA, Thompson-Hollands J, Fairholme CP, Ellard KK, Farchione TJ, Barlow DH. Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders. Depress Anxiety. 2010;27(10):882–90.CrossRefPubMed
12.
Barlow DH. Unified protocol for transdiagnostic treatment of emotional disorders : therapist guide. New York: Oxford University Press; 2011.
13.
Barlow DH, Ellard KK, Fairholme CP, Farchione TJ, Boisseau CL, Ehrenreich-May JT. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Work Book. New York: Oxford University Press; 2011.
14.
Norton PJ, Paulus DJ. Toward a Unified Treatment for Emotional Disorders: Update on the Science and Practice. Behavior Therapy. 2015 in press.
15.
Reinholt N, Krogh J. Efficacy of transdiagnostic cognitive behaviour therapy for anxiety disorders: a systematic review and meta-analysis of published outcome studies. Cogn Behav Ther. 2014;43(3):171–84.CrossRefPubMed
16.
Ellard KK, Fairholme CP, Boisseau CL, Farchione TJ, Barlow DH. Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders: Protocol Development and Initial outcome data. Cogn Behav Pract. 2010;17:88–101.CrossRef
17.
Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, Gallagher MW, Barlow DH. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther. 2012;43(3):666–78.CrossRefPubMedPubMedCentral
18.
Davis L, Barlow DH, Smith L. Comorbidity and the treatment of principal anxiety disorders in a naturalistic sample. Behav Ther. 2010;41(3):296–305.CrossRefPubMed
19.
de Ornelas Maia AC, Nardi AE, Cardoso A. The utilization of unified protocols in behavioral cognitive therapy in transdiagnostic group subjects: A clinical trial. J Affect Disord. 2015;172:179–83.CrossRefPubMed
20.
Bullis JR, Sauer-Zavala S, Bentley KH, Thompson-Hollands J, Carl JR, Barlow DH. The unified protocol for transdiagnostic treatment of emotional disorders: preliminary exploration of effectiveness for group delivery. Behav Modif. 2015;39(2):295–321.CrossRefPubMed
21.
Sauer-Zavala S, Bentley KH, Wilner JG. Transdiagnostic Treatment of Borderline Personality Disorder and Comorbid Disorders: A Clinical Replication Series. J Pers Disord. 2016;30(1):35–51.CrossRefPubMed
22.
Reinholt N, Aharoni R, Winding C, K. RN, Rosenbaum B, Arnfred SM. Transdiagnostic Group CBT for Anxiety Disorders: The Unified Protocol in Mental Health Services. Cognitive Behavior Therapy. 2016, in press.
23.
McDermut W, Miller IW, Brown RA. The efficacy of group therapy for depression: A meta-analysis and review of the empirical research. Clinical Psychology: Science and Practice. 2001;8(1):98–116.
24.
Digman. Personality Structure: Emergence of the five-factor model. Annu Rev Psychol. 1990;41(1):417–40.CrossRef
25.
APA. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.
26.
Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol. 1998;107(2):179–92.CrossRefPubMed
27.
Brown TA. Temporal course and structural relationships among dimensions of temperament and DSM-IV anxiety and mood disorder constructs. J Abnorm Psychol. 2007;116(2):313–28.CrossRefPubMed
28.
Carl JR, Gallagher MW, Sauer-Zavala SE, Bentley KH, Barlow DH. A preliminary investigation of the effects of the unified protocol on temperament. Compr Psychiatry. 2014;55(6):1426–34.CrossRefPubMedPubMedCentral
29.
Sauer-Zavala S, Boswell JF, Gallagher MW, Bentley KH, Ametaj A, Barlow DH. The role of negative affectivity and negative reactivity to emotions in predicting outcomes in the unified protocol for the transdiagnostic treatment of emotional disorders. Behav Res Ther. 2012;50(9):551–7.CrossRefPubMedPubMedCentral
30.
Dobson KS, Singer AR. Definitional and Practical Issues in the Assessment of Treatment Integrety. Clinical Psychology: Science and Practice. 2005;12(4):384–7.
31.
Lambert MJ, Barley DF. Research summary on the therapeutic relationship and psychotherapy outcome. Psychotherapy: Theory, Research, Practice, Training. 2001;38(4):357–61.CrossRef
32.
Kazdin AE. Treatment outcomes, common factors and continued neclect of mechanisms of change. Clinical Psychology: Science and Practice. 2005;12(2):184–8.
33.
Zilcha-Mano S, Muran JC, Hungr C, Eubanks CF, Safran JD, Winston A. The relationship between alliance and outcome: Analysis of a two-person perspective on alliance and session outcome. J Consult Clin Psychol. 2016;84(6):484–96.CrossRefPubMed
34.
Zilcha-Mano S, Snyder J, Silberschatz G. The effect of congruence in patient and therapist alliance on patient's symptomatic levels. Psychother Res. 2016;1–10.
35.
Turk C, Heimberg R, Magee L. Social Anxiety Disorder. In: Barlow DH, editor. Clinical handbook of psychological disorders. 4th ed. New York: Guilford Press; 2008. p. 123–63.
36.
Craske MG, Barlow D. Panic Disorder and Agoraphobia. In: Barlow DH, editor. Clinical handbook of psychological disorders. 4th ed. New York: Guilford Press; 2008. p. 1–64.
37.
Arendt, Rosenberg. Kognitiv terapi, 1. udgave edn. Kbh.: Hans Reitzel; 2012.
38.
Suhl S, Arpe-Moeller C, Gravesen L. Gruppemanual for panikangst og agorafobi: 2. og 3. bølge kognitiv adfærdsterapi. 2016.
39.
Due Madsen J. Kognitiv adfærdsterapi ved depression. Virum: Dansk psykologisk Forlag; 2008.
40.
Lau ME, Calmer J, Bramsen J, Madsen JD. Short-term treatment of depression. Implementation of group-based cognitive behavioral therapy. Ugeskr Laeger. 2008;170(15):1246–9.PubMed
41.
Scott MJ. Simply effective group cognitive behaviour therapy : a practitioner's guide. Hove, East Sussex England: Routledge; 2011.
42.
Boswell JF, Gallagher MW, Sauer-Zavala SE, Bullis J, Gorman JM, Shear MK, Woods S, Barlow DH. Patient characteristics and variability in adherence and competence in cognitive-behavioral therapy for panic disorder. J Consult Clin Psychol. 2013;81(3):443–54.CrossRefPubMed
43.
Lowe B, Spitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord. 2004;78(2):131–40.CrossRefPubMed
44.
Newnham EA, Hooke GR, Page AC. Monitoring treatment response and outcomes using the World Health Organization's Wellbeing Index in psychiatric care. J Affect Disord. 2010;122(1-2):133–8.CrossRefPubMed
45.
Newnham EA, Hooke GR, Page AC. Progress monitoring and feedback in psychiatric care reduces depressive symptoms. J Affect Disord. 2010;127(1-3):139–46.CrossRefPubMed
46.
Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res. 2003;12(2):85–91.CrossRefPubMed
47.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22–33. quiz 34-57.PubMed
48.
Moran P, Leese M, Lee T, Walters P, Thornicroft G, Mann A. Standardised Assessment of Personality - Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry. 2003;183:228–32.CrossRefPubMed
49.
Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959;32:50–5.CrossRefPubMed
50.
Bech P. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials. Pharmacol Toxicol. 2007;40(4):163–8.
51.
Meoni P, Salinas E, Brault Y, Hackett D. Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. J Clin Psychiatry. 2001;62(11):888–93.CrossRefPubMed
52.
Bech, Psykiatrisk Hospital i Hillerød. Rating scales for affektive lidelser [Rating scales for Affective Disorders]. Hillerød: Psykiatrisk Forskningsenhed; 2005.
53.
54.
Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG. Quantitative rating of depressive states. Acta Psychiatr Scand. 1975;51(3):161–70.CrossRefPubMed
55.
56.
Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.CrossRefPubMed
57.
Lipman RS, Covi L, Shapiro AK. The Hopkins Symptom Checklist (HSCL)--factors derived from the HSCL-90. J Affect Disord. 1979;1(1):9–24.CrossRefPubMed
58.
Müller J, Poster C, Beyer T, Furniss T, Actergarde S. Comparison of Eleven Short Versions of the Symptom Checklist 90-Revised (SCL-90-R) in the assessment of general Psychopathology. J Psychopathol Behav Assess. 2010;32:246–54.CrossRef
59.
Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol. 1988;54:1063–70.CrossRefPubMed
60.
Krohne HW, Egloff B, Kohlmann CW, Tausch A. Positive and Negative Affect Schedule (PANAS). Diagnostica. 1996;42:139–56.
61.
Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol. 2003;85(2):348–62.CrossRefPubMed
62.
Berking M, Wupperman P, Reichardt A, Pejic T, Dippel A, Znoj H. Emotion-regulation skills as a treatment target in psychotherapy. Behav Res Ther. 2008;46(11):1230–7.CrossRefPubMed
63.
Ehring T, Zetsche U, Weidacker K, Wahl K, Schonfeld S, Ehlers A. The Perseverative Thinking Questionnaire (PTQ): validation of a content-independent measure of repetitive negative thinking. J Behav Ther Exp Psychiatry. 2011;42(2):225–32.CrossRefPubMedPubMedCentral
64.
Ehring T, Watkins E. Repetitive Negative Thinking as a Transdiagnostic Process. Int J Cogn Ther. 2008;1(3):192–205.CrossRef
65.
Beck AT, Steer RA, Brown GK. Manual for the BDI. San Antonio, Texas: Th Psychological Corporation; 1996.
66.
Beck AT, Steer RA, Garbin MG. Psychometric Properties of the Beck Depression Inventory - 25 Years of Evaluation. Clin Psychol Rev. 1988;8(1):77–100.CrossRef
67.
Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461–4.CrossRefPubMed
68.
Zahra D, Qureshi A, Henley W, Taylor R, Quinn C, Pooler J, Hardy G, Newbold A, Byng R. The work and social adjustment scale: reliability, sensitivity and value. Int J Psychiatry Clin Pract. 2014;18(2):131–8.CrossRefPubMed
69.
Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233–7.CrossRefPubMed
70.
Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197–207.CrossRefPubMed
71.
Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, Gorman JM, Papp LA. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997;154(11):1571–5.CrossRefPubMed
72.
Bohni MK, Spindler H, Arendt M, Hougaard E, Rosenberg NK. A randomized study of massed three-week cognitive behavioural therapy schedule for panic disorder. Acta Psychiatr Scand. 2009;120(3):187–95.CrossRefPubMed
73.
Baker SL, Heinrichs N, Kim HJ, Hofmann SG. The liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis. Behav Res Ther. 2002;40(6):701–15.CrossRefPubMed
74.
Chambless DL, Caputo GC, Jasin SE, Gracely EJ, Williams C. The Mobility Inventory for Agoraphobia. Behav Res Ther. 1985;23(1):35–44.CrossRefPubMed
75.
Bender DS, Morey LC, Skodol AE. Toward a model for assessing level of personality functioning in DSM-5, part I: a review of theory and methods. J Pers Assess. 2011;93(4):332–46.CrossRefPubMed
76.
Association AP. Diagnostic and Statistical Manual of Mental Disorders (DSM-5\FFFD). 5th ed. Washington: American Psychiatric Publishing; 2013.CrossRef
77.
Hutsebaut J, Feenstra DJ, Kamphuis JH. Development and Preliminary Psychometric Evaluation of a Brief Self-Report Questionnaire for the Assessment of the DSM-5 level of Personality Functioning Scale: The LPFS Brief Form (LPFS-BF). Personal Disord. 2016;7(2):192–7.CrossRefPubMed
78.
79.
Fonagy P, Luyten P, Moulton-Perkins A, Lee Y-W, Warren F, Howard S, Ghinai R, Fearon P, Lowyck B. Development and Validation of a Self-Report Measure of Mentalizing: The Reflective Functioning Questionairre. PLoS One. 2016;11(7):1–28.CrossRef
80.
Ha C, Sharp C, Ensink K, Fonagy P, Cirino P. The measurement of reflective function in adolescents with and without borderline traits. J Adolesc. 2013;36(6):1215–23.CrossRefPubMed
81.
Krueger RF, Derringer J, Markon KE, Watson D, Skodol AE. Initial construction of a maladaptive personality trait model and inventory for DSM-5. Psychol Med. 2012;42(9):1879–90.CrossRefPubMed
82.
Bach B, Maples-Keller JL, Bo S, Simonsen E. The alternative DSM-5 personality disorder traits criterion: A comparative examination of three self-report forms in a Danish population. Personal Disord. 2016;7(2):124–35.CrossRefPubMed
83.
Bo S, Bach B, Mortensen EL, Simonsen E. Reliability and Hierarchical Structure of DSM-5 Pathological Traits in a Danish Mixed Sample. J Pers Disord. 2016;30(1):112–29.CrossRefPubMed
84.
Gray MJ, Litz BT, Hsu JL, Lombardo TW. Psychometric properties of the life events checklist. Assessment. 2004;11(4):330–41.CrossRefPubMed
85.
Lund R, Christensen U, Nilsson CJ, Kriegbaum M, Hulvej Rod N. Stressful social relations and mortality: a prospective cohort study. J Epidemiol Community Health. 2014;68(8):720–7.CrossRefPubMed
86.
Lund R, Nielsen LS, Henriksen PW, Schmidt L, Avlund K, Christensen U. Content validity and reliability of the Copenhagen social relations questionnaire. J Aging Health. 2014;26(1):128–50.CrossRefPubMed
87.
Norman SB, Allard CB, Trim RS, Thorp SR, Behrooznia M, Masino TT, Stein MB. Psychometrics of the Overall Anxiety Severity and Impairment Scale (OASIS) in a sample of women with and without trauma histories. Arch Womens Ment Health. 2013;16(2):123–9.CrossRefPubMed
88.
Norman SB, Cissell SH, Means-Christensen AJ, Stein MB. Development and validation of an Overall Anxiety Severity And Impairment Scale (OASIS). Depress Anxiety. 2006;23(4):245–9.CrossRefPubMed
89.
Bentley KH, Gallagher MW, Carl JR, Barlow DH. Development and validation of the Overall Depression Severity and Impairment Scale. Psychol Assess. 2014;26(3):815–30.CrossRefPubMed
90.
Krogel J, Burlingame G, Chapman C, Renshaw T, Gleave R, Beecher M, Macnair-Semands R. The Group Questionnaire: a clinical and empirically derived measure of group relationship. Psychother Res. 2013;23(3):344–54.CrossRefPubMed
91.
92.
Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol. 2007;3:1–27.CrossRefPubMed
93.
Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI. Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland. Health Technol Assess. 2005;9(42):1–174.CrossRefPubMed
94.
Jakobsen JC, Hansen JL, Storebo OJ, Simonsen E, Gluud C. The effects of cognitive therapy versus 'no intervention' for major depressive disorder. PLoS One. 2011;6(12):e28299.CrossRefPubMedPubMedCentral
Metadata
Title
Transdiagnostic group CBT vs. standard group CBT for depression, social anxiety disorder and agoraphobia/panic disorder: Study protocol for a pragmatic, multicenter non-inferiority randomized controlled trial
Authors
Sidse M. Arnfred
Ruth Aharoni
Morten Hvenegaard
Stig Poulsen
Bo Bach
Mikkel Arendt
Nicole K. Rosenberg
Nina Reinholt
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2017
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-1175-0

Other articles of this Issue 1/2017

BMC Psychiatry 1/2017 Go to the issue

Research article

Reduced functional connectivity between bilateral precuneus and contralateral parahippocampus in schizotypal personality disorder

Research article

More than eight in every nineteen inmates were living with depression at prisons of Northwest Amhara Regional State, Ethiopia, a cross sectional study design

Research article

Diagnostic performance and optimal cut-off scores of the Massachusetts youth screening instrument-second version in a sample of Swiss youths in welfare and juvenile justice institutions

Study protocol

Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illness

Research article

Brain donation in psychiatry: results of a Dutch prospective donor program among psychiatric cohort participants

Research article

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia